| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5616010 | The Journal of Heart and Lung Transplantation | 2017 | 31 Pages |
Abstract
Tanshinol suppresses cardiac allograft rejection by recruiting CD4+FoxP3+ Tregs to the graft, whereas rapamycin does so via expanding the Tregs. Thus, tanshinol cooperates with rapamycin to further extend cardiac allograft survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chuanjian MD, Yu-Qun PhD, Huazhen MS, Qingfeng MS, Shengmei MS, Kangsheng MD, PhD, Changwei MD, PhD, Zhenhua MD, PhD,